A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Malignancy|Advanced Solid Tumors|Neoplasm|Metastasis
Interventions: DRUG: SDX-7320
Sponsor: SynDevRx, Inc.